Funding for this research was provided by:
National Cancer Institute (R01CA237322)
Received: 16 February 2022
Accepted: 23 April 2022
First Online: 13 May 2022
: The study team received approval for all CAFÉ study activities from the Kaiser Permanente Washington Human Research Protections Program on July 01, 2021 (Package 1737325-13).
: Model consent forms are available upon request from the study principal investigators.
: The authors declare that they have no competing interests.